{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:16:43Z","timestamp":1788297403395,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["PZ2025003"],"award-info":[{"award-number":["PZ2025003"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["CCMU2024ZKYXY021"],"award-info":[{"award-number":["CCMU2024ZKYXY021"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["PYZ24129"],"award-info":[{"award-number":["PYZ24129"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbadis.2025.167978","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T16:10:01Z","timestamp":1752595801000},"page":"167978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism of ruxolitinib enhancing mitophagy against renal fibrosis via PINK1\/Parkin pathway"],"prefix":"10.1016","volume":"1871","author":[{"given":"He","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yige","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167978_bb0005","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2025.167978_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJMe2215286","article-title":"Chronic kidney disease - another step forward","volume":"388","author":"August","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.167978_bb0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJMra2308577","article-title":"Genetics of chronic kidney disease","volume":"391","author":"Vivante","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.167978_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167978_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.31083\/j.fbl2905192","article-title":"Kidney fibrosis and matrix metalloproteinases (MMPs)","volume":"29","author":"La Russa","year":"2024","journal-title":"Front Biosci (Landmark Ed)."},{"key":"10.1016\/j.bbadis.2025.167978_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167978_bb0035","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/cells10082014","article-title":"Different patterns of kidney fibrosis are indicative of injury to distinct renal compartments","volume":"10","author":"Tampe","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167978_bb0040","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.kint.2023.01.021","article-title":"Proteomic landscape of the extracellular matrix in the fibrotic kidney","volume":"103","author":"Li","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2025.167978_bb0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167978_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/invivo.11019","article-title":"Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies","volume":"31","author":"Nogueira","year":"2017","journal-title":"In Vivo"},{"key":"10.1016\/j.bbadis.2025.167978_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.814497","article-title":"New aspects of kidney fibrosis-from mechanisms of injury to modulation of disease","volume":"8","author":"Moeller","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.bbadis.2025.167978_bb0060","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3390\/biomedicines11102746","article-title":"Novel therapeutic approaches in the management of chronic kidney disease","volume":"11","author":"D\u0105bek","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbadis.2025.167978_bb0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/00325481.2023.2233492","article-title":"Novel therapeutic approaches in the management of chronic kidney disease: a narrative review","volume":"135","author":"Theofilis","year":"2023","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.bbadis.2025.167978_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MNH.0000000000000716","article-title":"Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease","volume":"30","author":"Smeijer","year":"2021","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbadis.2025.167978_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1101068","article-title":"Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: a comparative review","volume":"14","author":"Alshahrani","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.ajkd.2021.11.010","article-title":"Antifibrotic agents for the management of CKD: a review","volume":"80","author":"Ruiz-Ortega","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbadis.2025.167978_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.ackd.2016.11.002","article-title":"Treatment of renal fibrosis-turning challenges into opportunities","volume":"24","author":"Klinkhammer","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.bbadis.2025.167978_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/cells12010088","article-title":"Oxidative stress and mitochondrial dysfunction in chronic kidney disease","volume":"12","author":"Ho","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167978_bb0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2018.9","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"14","author":"Forbes","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41420-020-00316-9","article-title":"Mitochondrial dysfunction in fibrotic diseases","volume":"6","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167978_bb0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12013-014-0231-y","article-title":"Nephroprotective effect of gelsemine against cisplatin-induced toxicity is mediated via attenuation of oxidative stress","volume":"71","author":"Lin","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2025.167978_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ki.2013.80","article-title":"A microRNA-30e\/mitochondrial uncoupling protein 2 axis mediates TGF-\u03b21-induced tubular epithelial cell extracellular matrix production and kidney fibrosis","volume":"84","author":"Jiang","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2025.167978_bb0115","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00285.2020","article-title":"Mitochondrial dysfunction and the AKI-to-CKD transition","volume":"319","author":"Jiang","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-024-01360-6","article-title":"EPRS1-mediated fibroblast activation and mitochondrial dysfunction promote kidney fibrosis","author":"Son","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2025.167978_bb0125","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4103\/0366-6999.245272","article-title":"Renal fibrosis and mitochondrial damage","volume":"131","author":"Qin","year":"2018","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbadis.2025.167978_bb0130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/cells10030537","article-title":"Cell death and inflammation: the role of mitochondria in health and disease","volume":"10","author":"Picca","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167978_bb0135","first-page":"332","article-title":"Mitochondrial dynamics, ROS, and cell signaling: a blended overview","volume":"11","author":"Brillo","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.bbadis.2025.167978_bb0140","doi-asserted-by":"crossref","first-page":"121432","DOI":"10.1016\/j.lfs.2023.121432","article-title":"Mitochondrial dysfunction and oxidative stress: role in chronic kidney disease","volume":"319","author":"Srivastava","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.167978_bb0145","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/biof.1673","article-title":"Mitochondrial dysfunction and endoplasmic reticulum stress in the promotion of fibrosis in obstructive nephropathy induced by unilateral ureteral obstruction","volume":"46","author":"Mart\u00ednez-Klimova","year":"2020","journal-title":"Biofactors"},{"key":"10.1016\/j.bbadis.2025.167978_bb0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.freeradbiomed.2019.12.005","article-title":"Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction","volume":"152","author":"Li","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2025.167978_bb0155","doi-asserted-by":"crossref","first-page":"155913","DOI":"10.1016\/j.metabol.2024.155913","article-title":"Role of mitochondria in pathogenesis and therapy of renal fibrosis","volume":"155","author":"Zhao","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2025.167978_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11255-023-03686-y","article-title":"Mitophagy in renal interstitial fibrosis","volume":"56","author":"Sun","year":"2024","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0165","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/ctm2.1686","article-title":"Rictor\/mTORC2 signalling contributes to renal vascular endothelial-to-mesenchymal transition and renal allograft interstitial fibrosis by regulating BNIP3-mediated mitophagy","volume":"14","author":"Feng","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbadis.2025.167978_bb0170","first-page":"13","article-title":"The emerging role of mitophagy in kidney diseases","volume":"1","author":"Bhatia","year":"2019","journal-title":"J Life Sci (Westlake Village)."},{"key":"10.1016\/j.bbadis.2025.167978_bb0175","doi-asserted-by":"crossref","first-page":"17260","DOI":"10.7717\/peerj.17260","article-title":"The role of mitophagy in the development of chronic kidney disease","volume":"12","author":"Yang","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.bbadis.2025.167978_bb0180","doi-asserted-by":"crossref","first-page":"118247","DOI":"10.1016\/j.lfs.2020.118247","article-title":"PINK1: the guard of mitochondria","volume":"259","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.167978_bb0185","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","article-title":"The role of PINK1-Parkin in mitochondrial quality control","volume":"26","author":"Narendra","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0190","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/cells10113022","article-title":"Disruption of mitochondrial homeostasis: the role of PINK1 in Parkinson\u2019s disease","volume":"10","author":"Vizziello","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167978_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.890823","article-title":"PINK1\/Parkin pathway activation for mitochondrial quality control - which is the best molecular target for therapy?","volume":"14","author":"Silvian","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2025.167978_bb0200","doi-asserted-by":"crossref","first-page":"129894","DOI":"10.1016\/j.bbagen.2021.129894","article-title":"A mechanistic review of Parkin activation","volume":"1865","author":"Gundogdu","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbadis.2025.167978_bb0205","doi-asserted-by":"crossref","first-page":"110631","DOI":"10.1016\/j.cellsig.2023.110631","article-title":"Parkin and mitochondrial signalling","volume":"106","author":"Connelly","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2025.167978_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nbd.2018.07.015","article-title":"Mechanisms of selective autophagy and mitophagy: implications for neurodegenerative diseases","volume":"122","author":"Chu","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2025.167978_bb0215","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1080\/15548627.2022.2062111","article-title":"LC3 subfamily in cardiolipin-mediated mitophagy: a comparison of the LC3A, LC3B and LC3C homologs","volume":"18","author":"Iriondo","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2025.167978_bb0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13045-023-01471-z","article-title":"Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety","volume":"16","author":"Verstovsek","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/1744666X.2023.2161511","article-title":"Ruxolitinib cream for the short-term treatment of mild-moderate atopic dermatitis","volume":"19","author":"Krajewski","year":"2023","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0230","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/09546634.2020.1773385","article-title":"Off-label studies on ruxolitinib in dermatology: a review","volume":"33","author":"Wu","year":"2022","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.bbadis.2025.167978_bb0235","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00277-019-03708-9","article-title":"Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis","volume":"98","author":"Strati","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bbadis.2025.167978_bb0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7150\/ijbs.39024","article-title":"Ruxolitinib alleviates renal interstitial fibrosis in UUO mice","volume":"16","author":"Bai","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2025.167978_bb0245","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/jcm13071881","article-title":"Fibrosis in chronic kidney disease: pathophysiology and therapeutic targets","volume":"13","author":"Reiss","year":"2024","journal-title":"J. Clin. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925003266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925003266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:46:27Z","timestamp":1788295587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925003266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0925443925003266"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167978","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of ruxolitinib enhancing mitophagy against renal fibrosis via PINK1\/Parkin pathway","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167978"}}